Cost Effectiveness of First-Line Oral Therapies for Pulmonary Arterial Hypertension: A Modelling Study.

Autor: Coyle K; Brunel University, Gaskell building, Uxbridge, Middlesex, UB8 3PH, UK. Kathryn.Coyle@brunel.ac.uk., Coyle D; Brunel University, Gaskell building, Uxbridge, Middlesex, UB8 3PH, UK.; University of Ottawa, Ottawa, ON, Canada., Blouin J; Canadian Agency for Drugs and Technologies in Health (CADTH), Ottawa, ON, Canada., Lee K; Canadian Agency for Drugs and Technologies in Health (CADTH), Ottawa, ON, Canada., Jabr MF; Canadian Agency for Drugs and Technologies in Health (CADTH), Ottawa, ON, Canada., Tran K; Canadian Agency for Drugs and Technologies in Health (CADTH), Ottawa, ON, Canada., Mielniczuk L; University of Ottawa Heart Institute, Ottawa, ON, Canada., Swiston J; University of British Columbia, Vancouver, BC, Canada., Innes M; Canadian Agency for Drugs and Technologies in Health (CADTH), Ottawa, ON, Canada.

Publikováno v: PharmacoEconomics [Pharmacoeconomics] 2016 May; Vol. 34 (5), pp. 509-20.